NaoXinTong Inhibits the Development of Diabetic Retinopathy in <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" style="vertical-align:-2.9558pt" id="M1" height="15.7306pt" version="1.1" viewBox="-0.0657574 -12.7748 44.2901 15.7306" width="44.2901pt"><g transform="matrix(.018,0,0,-0.018,0,0)"><path id="g113-101" d="M530 686C535 705 530 712 521 712C504 712 448 684 359 674L358 648H393C437 648 439 646 429 593L400 435C372 447 345 448 332 448C286 448 194 414 144 373C68 311 23 203 23 111C23 26 57 -12 91 -12C120 -12 147 3 188 29C227 54 290 102 341 170H343L322 71C308 6 320 -12 341 -12C373 -12 442 27 501 96L485 120C455 91 422 67 408 67C401 67 401 76 404 91C440 294 479 473 530 686ZM387 375L355 241C326 187 200 53 142 53C126 53 109 73 109 130C109 217 154 337 218 381C240 396 265 404 297 404S372 390 387 375Z"/></g><g transform="matrix(.018,0,0,-0.018,9.925,0)"><path id="g113-99" d="M452 333C452 398 425 448 375 448C329 448 235 404 140 292H138L229 683C233 701 234 712 225 712C208 712 149 686 66 677L64 652H97C135 652 140 651 129 598L38 167C23 96 29 57 44 33C60 7 98 -12 132 -12C169 -12 232 3 290 41C383 102 452 223 452 333ZM365 316C365 199 308 87 239 49C221 39 200 35 183 35C137 35 99 70 112 163C116 191 123 215 129 233C190 316 290 392 330 392C348 392 365 372 365 316Z"/></g><g transform="matrix(.018,0,0,-0.018,18.319,0)"><path id="g113-48" d="M368 703H309L44 -163H104L368 703Z"/></g><g transform="matrix(.018,0,0,-0.018,25.694,0)"><use xlink:href="#g113-101"/></g><g transform="matrix(.018,0,0,-0.018,35.62,0)"><use xlink:href="#g113-99"/></g></svg> Mice

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Gene</td><td align="left">Forward</td><td align="left">Backward</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">CAS-3</td><td align="left">GACTTGCTCCCATGTATGGTC</td><td align="left">ATCAAAGCGCAGTGTCCTG</td></tr><tr><td align="left">MMP-2</td><td align="left">TGGCAAGGTGTGGTGTGCGAC</td><td align="left">TCGGGGCCATCAGAGCTCCAG</td></tr><tr><td align="left">MMP-9</td><td align="left">GGTGTGCCCTGGAACTCACACG</td><td align="left">AGGGCACTGCAGGAGGTCGT</td></tr><tr><td align="left">TNF<svg height="6.42315pt" id="M6" style="vertical-align:-0.2129903pt" version="1.1" viewbox="-0.0498162 -6.21016 7.82384 6.42315" width="7.82384pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M545 106L524 126C493 85 467 65 455 65C438 65 427 113 405 238C448 295 498 362 543 439L533 448L478 435C453 386 423 331 398 295H395C370 404 347 448 282 448C169 448 23 309 23 153C23 54 65 -12 128 -12C203 -12 283 70 339 155H341C360 29 380 -12 411 -12C444 -12 491 11 545 106ZM333 204C265 95 210 54 169 54C137 54 113 96 113 171C113 302 191 405 252 405C301 405 318 306 333 204Z" id="g113-223"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="568" vert-adv-y="568"></glyph.data></g></svg></td><td align="left">GTTCTATGGCCCAGACCCTCAC</td><td align="left">GGCACCACTAGTTGGTTGTCTTTG</td></tr><tr><td align="left"><svg height="13.2498pt" id="M7" style="vertical-align:-3.571899pt" version="1.1" viewbox="-0.0498162 -9.6779 8.00062 13.2498" width="8.00062pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M558 587C558 666 497 712 432 712C379 712 330 691 284 650C212 586 178 508 148 348L71 -65C49 -185 35 -229 23 -235L27 -261C49 -259 101 -251 124 -224C131 -216 138 -178 159 -24C171 66 197 200 227 356C264 550 295 668 393 668C443 668 479 632 479 575C479 516 446 458 383 418C361 404 344 398 318 397L296 350C395 338 460 281 460 192C460 110 411 40 300 40C258 40 215 55 192 69L181 51C191 18 222 -16 266 -16C308 -16 351 1 397 26C471 67 545 142 545 221C545 315 486 365 401 395C469 437 558 498 558 587Z" id="g113-224"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="581" vert-adv-y="581"></glyph.data></g></svg>-actin</td><td align="left">ATCTGGCACCACACCTTC</td><td align="left">AGCCAGGTCCAGACGCA</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Sequences of the primers for real time RT-PCR analysis.

Evidence-Based Complementary and Alternative Medicine

tab1

Table 1

Table 1: NaoXinTong Inhibits the Development of Diabetic Retinopathy in <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" style="vertical-align:-2.9558pt" id="M1" height="15.7306pt" version="1.1" viewBox="-0.0657574 -12.7748 44.2901 15.7306" width="44.2901pt"><g transform="matrix(.018,0,0,-0.018,0,0)"><path id="g113-101" d="M530 686C535 705 530 712 521 712C504 712 448 684 359 674L358 648H393C437 648 439 646 429 593L400 435C372 447 345 448 332 448C286 448 194 414 144 373C68 311 23 203 23 111C23 26 57 -12 91 -12C120 -12 147 3 188 29C227 54 290 102 341 170H343L322 71C308 6 320 -12 341 -12C373 -12 442 27 501 96L485 120C455 91 422 67 408 67C401 67 401 76 404 91C440 294 479 473 530 686ZM387 375L355 241C326 187 200 53 142 53C126 53 109 73 109 130C109 217 154 337 218 381C240 396 265 404 297 404S372 390 387 375Z"/></g><g transform="matrix(.018,0,0,-0.018,9.925,0)"><path id="g113-99" d="M452 333C452 398 425 448 375 448C329 448 235 404 140 292H138L229 683C233 701 234 712 225 712C208 712 149 686 66 677L64 652H97C135 652 140 651 129 598L38 167C23 96 29 57 44 33C60 7 98 -12 132 -12C169 -12 232 3 290 41C383 102 452 223 452 333ZM365 316C365 199 308 87 239 49C221 39 200 35 183 35C137 35 99 70 112 163C116 191 123 215 129 233C190 316 290 392 330 392C348 392 365 372 365 316Z"/></g><g transform="matrix(.018,0,0,-0.018,18.319,0)"><path id="g113-48" d="M368 703H309L44 -163H104L368 703Z"/></g><g transform="matrix(.018,0,0,-0.018,25.694,0)"><use xlink:href="#g113-101"/></g><g transform="matrix(.018,0,0,-0.018,35.62,0)"><use xlink:href="#g113-99"/></g></svg> Mice 

Evidence-Based Complementary and Alternative Medicine

NaoXinTong Inhibits the Development of Diabetic Retinopathy in Mice

Table 1